Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,329,760
+$2,037,066 QoQ
Shares Held
11,892
+145.4% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#301
of 1,044 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CAXTON ASSOCIATES LLP holds $13,856,089 across 7 Diagnostics & Research names. LH ranks #2 (24.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
24,074 | $4,585,615 | |
| 2 | LH |
Labcorp Holdings Inc.
This page
|
11,892 | $3,329,760 | |
| 3 | GH |
Guardant Health, Inc.
|
20,127 | $3,019,653 | |
| 4 | FLGT |
Fulgent Genetics, Inc.
|
62,069 | $1,273,655 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
1,722 | $863,341 | |
| 6 | A |
Agilent Technologies, Inc.
|
3,080 | $409,116 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
708 | $374,949 |
All Filings in LH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,329,760 | 11,892 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,292,694 | 4,845 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,713,761 | 6,831 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,960,906 | 6,831 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $699,589 | 2,665 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,575,035 | 11,064 | Shares | Sole | 2025-05-16 | |
| No filing history on record for this holder in this stock. | ||||||